Facilitation of amphetamine-induced rotation by muscarinic antagonists is correlated with M2 receptor affinity.
This study examined the relationship between the affinity of cholinergic drugs for muscarinic receptor subtypes and their potency in potentiating or inhibiting amphetamine-induced rotation. The ascending nigrostriatal dopaminergic pathway was unilaterally lesioned in male Wistar rats using 6-hydroxydopamine. In these rats, ipsiversive rotation induced by amphetamine sulphate (1 mg/kg, s.c.) was dose-dependently inhibited by the cholinergic agonists oxotremorine, RS86 and pilocarpine and by the acetylcholinesterase inhibitor physostigmine. In contrast the cholinergic antagonists scopolamine, secoverine and dicyclomine facilitated amphetamine-induced rotation. Agonist and antagonist potencies were then compared with M1 and M2 binding site affinities estimated by displacing [3H]pirenzepine from forebrain and [3H]QNB from brainstem homogenates. The data suggest a relationship between antagonist potency and M2 binding site affinity.
D000818:Animals; D003913:Dextroamphetamine / Q000008:administration & dosage*; D004025:Dicyclomine / Q000008:administration & dosage; D004347:Drug Interactions; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D010276:Parasympatholytics / Q000008:administration & dosage*; D010277:Parasympathomimetics / Q000008:administration & dosage; D010627:Phenethylamines / Q000008:administration & dosage; D010830:Physostigmine / Q000008:administration & dosage; D051381:Rats; D011919:Rats, Inbred Strains; D011976:Receptors, Muscarinic / Q000187:drug effects*; D012601:Scopolamine / Q000008:administration & dosage
D010276:Parasympatholytics; D010277:Parasympathomimetics; D010627:Phenethylamines; D011976:Receptors, Muscarinic; D004025:Dicyclomine; C028187:secoverine; D010830:Physostigmine; D012601:Scopolamine; D003913:Dextroamphetamine